Last updated on August 2019

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney


Brief description of study

A Multicenter, Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study of ANG-3777 to Reduce the Severity of Delayed Graft Function in Recipients of a Deceased Donor Kidney.

The major objective is to demonstrate the safety and efficacy of ANG-3777 in reducing the severity of delayed graft function (DGF) in recipients at high risk of DGF after receiving a deceased donor renal allograft.

Clinical Study Identifier: NCT02474667

Find a site near you

Start Over

University of Louisville

Louisville, KY United States
  Connect »